Email Nudges to Improve GDMT (MRA) Adherence in Heart Failure - Trial NCT05806970
Access comprehensive clinical trial information for NCT05806970 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, Los Angeles and is currently Not yet recruiting. The study focuses on Heart Failure With Reduced Ejection Fraction. Target enrollment is 150 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of California, Los Angeles
Timeline & Enrollment
N/A
Apr 01, 2023
Jul 01, 2023
Primary Outcome
Percentage of eligible patients prescribed MRA
Summary
The Email Nudges to Improve GDMT (MRA) Adherence in Heart Failure (ENIGMA-HF) study is a
 pragmatic parallel-arm randomized control trial of a quality improvement (QI) intervention
 involving email nudges to cardiology clinic managers to schedule appointments specific to
 guideline directed medical therapy (GDMT) initiation, with the goal of optimizing
 mineralocorticoid-receptor antagonist (MRA) use by patients with heart failure with reduced
 ejection fraction (HFrEF) cared for by cardiologists within the University of California, Los
 Angeles (UCLA) Health System.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05806970
Non-Device Trial